U.S. CDC panel endorses Pfizer booster shot for elderly, high-risk people

2021-09-24 08:15:16Xinhua Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

A U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions.

The panel voted 15-0 to recommend a booster dose for Americans age 65 and older and people in long term care facilities. It also fully recommended giving a single booster dose to people between the ages of 50 and 64 with certain high risk conditions, by a vote of 13-2.

On Wednesday, the Food and Drug Administration approved Pfizer boosters for people aged 65 and older or at high-risk. The extra dose would be given once they are at least six months past their last Pfizer shot.

CDC Director Rochelle Walensky is expected to accept the panel's endorsement shortly. 


Most popular in 24h

MoreTop news


Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2021 All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[京公网安备 11010202009201号] [京ICP备05004340号-1]